Skip to main content
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest
  • facebook
  • twitter
  • linkedin
  • youtube
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest

Safety and Immunogenicity Study of GX-19, a COVID-19 Preventive DNA Vaccine in Healthy Adults

  • Read more about Safety and Immunogenicity Study of GX-19, a COVID-19 Preventive DNA Vaccine in Healthy Adults

ANalyzing Olfactory Dysfunction Mechanisms In COVID-19

  • Read more about ANalyzing Olfactory Dysfunction Mechanisms In COVID-19

Mesenchymal Stromal Cell Therapy for Severe Covid-19 Infection

  • Read more about Mesenchymal Stromal Cell Therapy for Severe Covid-19 Infection

Mesenchymal Stromal Cell Therapy For The Treatment Of Acute Respiratory Distress Syndrome

  • Read more about Mesenchymal Stromal Cell Therapy For The Treatment Of Acute Respiratory Distress Syndrome

Impact of the COVID-19 Pandemic and HRQOL in Cancer Patients and Survivors

  • Read more about Impact of the COVID-19 Pandemic and HRQOL in Cancer Patients and Survivors

Determinants of SARS (Severe Acute Respiratory Syndrome)-COV2 (COVID-19) Persistence After Convalescence

  • Read more about Determinants of SARS (Severe Acute Respiratory Syndrome)-COV2 (COVID-19) Persistence After Convalescence

COVID-19: Longitudinal Study of Seroprevalence of SARS-CoV-2 Antibodies and Development of Immunity in School Children

  • Read more about COVID-19: Longitudinal Study of Seroprevalence of SARS-CoV-2 Antibodies and Development of Immunity in School Children

COVID-19 and Rare Skin Diseases European Observational Study During an Epidemic

  • Read more about COVID-19 and Rare Skin Diseases European Observational Study During an Epidemic

Use of hUC-MSC Product (BX-U001) for the Treatment of COVID-19 With ARDS

  • Read more about Use of hUC-MSC Product (BX-U001) for the Treatment of COVID-19 With ARDS

NA-831, Atazanavir and Dexamethasone Combination Therapy for the Treatment of COVID-19 Infection

  • Read more about NA-831, Atazanavir and Dexamethasone Combination Therapy for the Treatment of COVID-19 Infection

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 198
  • Page 199
  • Page 200
  • Page 201
  • Current page 202
  • Page 203
  • Page 204
  • Page 205
  • Page 206
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Subscribe for updates from the Reagan-Udall Foundation for the FDA

Subscribe
(202) 849 - 2075
1333 New Hampshire Ave, NW
Suite 420
Washington, DC 20036
navigator@reaganudall.org
  • facebook
  • twitter
  • linkedin
  • youtube

© Reagan-Udall Foundation for the FDA
© Reagan-Udall Foundation for the FDA